Francis Paul Worden

 Francis P. Worden
Clinical Professor
Available to mentor
Francis Paul Worden
Francis P. Worden
Clinical Professor
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Center Memberships
    • Center Member
      Rogel Cancer Center

    Recent Publications

     See All Publications
    • Journal Article
      Twelve-Month Swallowing Outcomes in a Phase II Trial of PET-Adapted Radiation for HPV-Associated Oropharynx Squamous Cell Carcinoma
      Higgins L, Suresh K, Wilkins S, Lyden T, Blakely A, Ambrose M, Elliott DA, Strohbehn G, Prince ME, Casper K, Shuman A, Stucken CL, Forner D, Heft-Neal ME, Yalamanchi P, Brenner C, Swiecicki PL, Worden F, Mierzwa ML, Shah JL. International Journal of Radiation Oncology • Biology • Physics, 2026 Sep 27; 126 (1): e689 - e690. DOI:10.1016/j.ijrobp.2026.06.2147
    • Journal Article
      UMCC 2023.006: A Pilot Phase II Trial of Individualized FDG-PET and DCE-MRI Directed Adaptive RT in HPV-related Stage III Oropharynx Cancer
      Higgins L, Suresh K, Shah JL, Nasser B, Casper K, Prince ME, Forner D, Buchakjian M, Heft-Neal ME, Yalamanchi P, Rosen BS, Shuman A, Stucken CL, Brenner C, D'Silva N, Swiecicki PL, Worden F, Mierzwa ML. International Journal of Radiation Oncology • Biology • Physics, 2026 Sep 27; 126 (1): e689 DOI:10.1016/j.ijrobp.2026.06.2146
    • Journal Article
      Reply to: Therapeutic Strategy Concerns for BRAF V600E-Mutated Differentiated Thyroid Cancer.
      Saba NF, Ismaila N, Worden F, Beadle BM. J Clin Oncol, 2026 Aug 6; JCO2601611 DOI:10.1200/JCO-26-01611
      PMID: 42561167
    • Journal Article
      Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancer.
      Bandaru R, Fu H, Zheng H, Liang J, Wang L, Gulati S, Hinrichs BH, Teng M, Zhang B, Kocherginsky M, Lin D-C, Hildeman DA, Worden FP, Old MO, Dunlap NE, Kaczmar JM, Gillison ML, El-Gamal D, Wise Draper T, Liu Y. J Clin Invest, 2026 May 19; DOI:10.1172/JCI196284
      PMID: 42154530
    • Journal Article
      Validation of MyHPVscore: a high-performance HPV ctDNA lab developed test
      Mierzwa M, Brenner C. Journal of Molecular Diagnostics, 2026 Apr 30;
    • Journal Article
      BTCRC HN17-111: A Phase 2 Trial of Androgen Deprivation Therapy (ADT) and Pembrolizumab for Treatment of Advanced-Stage Androgen Receptor (AR)-Positive Salivary Gland Carcinoma
      Bruce JY, Fujioka N, Worden F, Mehra R, Laux D, Chae YK, Sulahadeen A, Pease D, Cao Q, Kimple R, Garcia A, Patel MR. International Journal of Radiation Oncology • Biology • Physics, 2026 Apr 18; 125 (1): e23 DOI:10.1016/j.ijrobp.2026.02.046
    • Journal Article
      Late Recurrences Beyond Five Years in Salivary Adenoid Cystic Carcinoma: Implications for Long-Term Surveillance
      Dalal PJ, Dermody SM, Ali H, Brummel C, Chad Brenner J, Buchakjian M, Casper KA, Chinn SB, Forner D, Hasan D, Malloy KM, McHugh J, Mierzwa M, Heft Neal ME, Prince ME, Shah J, Shuman AG, Stucken CL, Spector ME, Yalamanchi P, Worden FP, Swiecicki PL. Oto Open, 2026 Apr 1; 10 (2): DOI:10.1002/oto2.70259
    • Journal Article
      Systemic Treatment of Thyroid Cancer: ASCO Guideline.
      Saba NF, Ismaila N, Adkins D, Agrawal N, Akhave N, Blomain ES, Cabanillas ME, Chen A, Galloway TJ, Harada G, Li D, Noureldine SI, Scharpf J, Sun LL, Tang M, Wirth L, Worden F, Zandberg DP, Beadle BM. J Clin Oncol, 2026 Apr 1; JCO2600235 DOI:10.1200/JCO-26-00235
      PMID: 41921121